Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
---|
05/05/2009 | US7528167 Inhibitors of papilloma virus |
05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
04/30/2009 | WO2009055357A1 Diazepane compounds which modulate the cb2 receptor |
04/30/2009 | WO2009055331A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
04/30/2009 | WO2009054814A1 Functionalized poly (3,4-alkylenebridgedthiophene) (pabt) |
04/30/2009 | WO2009053715A1 Thienopyrimidiene derivatives as pi3k inhibitors |
04/30/2009 | WO2009053268A1 Novel phenyl-substituted piperazino-dihydrothienopyrimidines |
04/30/2009 | WO2009028900A3 Oral administration drug comprising clopidogrel besylate |
04/30/2009 | US20090111835 Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group |
04/30/2009 | US20090111195 Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
04/30/2009 | CA2703203A1 Bicyclic heterocycle derivatives and methods of use thereof |
04/30/2009 | CA2702772A1 Diazepane compounds which modulate the cb2 receptor |
04/30/2009 | CA2702447A1 New phenyl-substituted piperazino-dihydrothienopyrimidines |
04/30/2009 | CA2701292A1 Process for making thienopyrimidine compounds |
04/30/2009 | CA2701276A1 Thienopyrimidiene derivatives as pi3k inhibitors |
04/29/2009 | EP2053393A1 Pladienolide target molecule, compound capable of binding to the target molecule, and screening method for the compound |
04/29/2009 | EP2051983A1 Ntetrahydropyridothiophene derivatives for the treatment of cancer |
04/29/2009 | EP2051982A1 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors |
04/29/2009 | EP2051711A1 Thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
04/29/2009 | EP1438288B1 Substituted thioacetamides |
04/29/2009 | CN101421268A Pyrazoloquinolones as potent PARP inhibitors |
04/29/2009 | CN101421265A Thiazole compounds as protein kinase b (pkb) inhibitors |
04/28/2009 | US7524922 Poly(benzodithiophenes) |
04/28/2009 | US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
04/28/2009 | US7524861 Process for the preparation of a hydrate of an anthranilic acid derivative |
04/28/2009 | US7524853 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes |
04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
04/23/2009 | WO2009052138A1 Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein |
04/23/2009 | WO2009051244A1 Heterocyclic compound |
04/23/2009 | WO2009051112A1 Amide compounds and use of the same |
04/23/2009 | WO2009050248A1 Substituted piperidino-dihydrothienopyrimidines |
04/23/2009 | WO2009050242A2 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
04/23/2009 | WO2009050236A1 Novel piperazino-dihydrothienopyrimidine derivatives |
04/23/2009 | WO2009049743A1 5-cyano-thienopyridines for the treatment of tumors |
04/23/2009 | WO2009017719A3 Modulators of ccr9 receptor and methods of use thereof |
04/23/2009 | US20090105289 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
04/23/2009 | US20090105244 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor |
04/23/2009 | US20090105233 Serine-threonine protein kinase and parp modulators |
04/23/2009 | US20090105227 Thienopyrroles As Antiviral Agents |
04/23/2009 | DE102007049451A1 5-Cyano-thienopyridine 5-cyano-thienopyridine |
04/23/2009 | CA2705414A1 Substituted piperidino-dihydrothienopyrimidines |
04/23/2009 | CA2702551A1 5-cyanothienopyridines |
04/23/2009 | CA2702524A1 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
04/23/2009 | CA2702518A1 New piperazino-dihydrothienopyrimidine derivatives |
04/23/2009 | CA2702500A1 Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein |
04/22/2009 | EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
04/22/2009 | EP2049536A2 Polycyclic viral inhibitors |
04/22/2009 | EP2049472A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
04/22/2009 | EP1539761B1 6,7-dihydro-5h-pyrazolo¬1,2-a pyrazol-1-ones which control inflammatory cytokines |
04/22/2009 | CN101415715A Fused ring compound and method for producing same, polymer, organic thin film containing those, and organic thin film device and organic thin film transistor comprising such organic thin film |
04/22/2009 | CN101415708A HIV inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones |
04/22/2009 | CN101412726A Novel heterocyclic compounds |
04/22/2009 | CN101412721A 6,13-substituted pentacene and derivatives thereof, as well as preparation |
04/22/2009 | CN101412651A Pentacenes and derivatives thereof, as well as thereof |
04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
04/21/2009 | US7521460 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor |
04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
04/21/2009 | CA2228038C 2(1h)-quinolone derivatives, their preparation and their use in therapy |
04/16/2009 | US20090099363 Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate |
04/16/2009 | US20090099356 Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction |
04/16/2009 | US20090098133 3-Cyano-2-[3-(2-ethoxy-phenyl)-propanoylamino]-4,7-dihydro-5H-thieno[2,3-c]pyridine-6-carboxylic acid tert-butyl ester; cell-cycle specific inducers of apoptosis in cancer cells |
04/16/2009 | US20090098086 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors |
04/15/2009 | EP2046799A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them |
04/14/2009 | US7518000 For therapy of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK); 2-(1H-thieno[3,2-c]pyrazol-3-yl)-1H-benzimidazole |
04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
04/14/2009 | US7517986 Such as N-(6-ethoxycarbonyl-3-cyano-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)nicotinamide; cell-cycle specific inducers of apoptosis specific to cells with aberrant cell growth |
04/14/2009 | US7517904 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
04/14/2009 | US7517879 Pyrrolidine derivatives as factor Xa inhibitors |
04/14/2009 | US7517532 Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
04/14/2009 | US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
04/09/2009 | WO2008058285A3 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors |
04/09/2009 | US20090093635 PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE |
04/09/2009 | US20090093629 Process for preparation of triazol-benzodiazepine derivatives |
04/09/2009 | US20090093456 Novel mch receptor antagonists |
04/08/2009 | EP2045252A2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
04/08/2009 | EP2044083A1 Antiviral agents |
04/08/2009 | EP2044082A1 Substituted benzodithiophenes and benzodiselenophenes |
04/08/2009 | EP2043612A1 A stable olanzapine formulation with antioxidants |
04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
04/08/2009 | CN101402643A Industrial production method for prasugrel |
04/08/2009 | CN101402642A Novel environment friendly preparation method for prasugrel |
04/08/2009 | CN101402641A Oxime derivatives containing thienopyridine, preparation method and application thereof |
04/08/2009 | CN101402556A New compound 1-cyclopropyl-2-(2-fluorine phenyl)-2-hydroxyl ethanone, preparation method and application thereof |
04/07/2009 | CA2400554C Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
04/02/2009 | WO2009041591A1 Fused pyridine derivative |
04/02/2009 | WO2008124000A3 Thiazole derivatives as androgen receptor modulator compounds |
04/02/2009 | WO2008106019A3 Fused thiophenes, methods for making fused thiophenes, and uses thereof |
04/02/2009 | WO2007032818A3 Compounds and compositions to control abnormal cell growth |
04/01/2009 | EP2041143A1 Quinazoline derivatives, their preparation, their use as tyrosine kinase inhibitors and medicaments comprising them |
04/01/2009 | EP2041124A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
04/01/2009 | EP2001889A4 Method for preparing clopidogrel 1,5-naphthalenedisulfonate or hydrate thereof |
04/01/2009 | EP1994013A4 PROCESS FOR PRODUCING PURE AND STABLE FORM OF 2-METHYL-4-(4- METHYL- 1 -PIPERAZINYL)-10H-THIENO[2,3-b] [1,5]BENZODIAZEPINE |
04/01/2009 | EP1899354B1 Synthesis of deoxybiotinyl hexamethylenediamine-dota |
04/01/2009 | EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
04/01/2009 | EP1312671B1 Magnetic particles having lower limit critical solution temperature |
04/01/2009 | CN101400683A Process for the preparation of olanzapine |
04/01/2009 | CN101400674A Antibiotic compounds |
04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |